✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Revolution Medicines Inc

Common Name
Revolution Medicines
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
809
Ticker
RVMD
Exchange
NASDAQ/NGS
Description
Revolution Medicines is a late-stage clinical oncology company focused on developing targeted therapies for cancers driven by the RAS protein, one of the most common cancer drivers affecting approxima...

Revolution Medicines's Financial Statements Preview

Below are the financial statements of Revolution Medicines, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Revenue
Collaboration revenue
0a
11.58a
35.38a
Total revenue
0a
11.58a
35.38a
Operating expenses
Research and development
-592.23a
-423.14a
-253.07a
General and administrative
-97.3a
-75.62a
-40.59a
Total operating expenses
-689.52a
-498.77a
-293.66a
Loss from operations
-689.52a
-487.19a
-258.28a
Other income (expense), net
Interest income
86.88a
47.48a
9.15a
Other expense
-2.53a
-0.3a
0a
Change in fair value of warrant liability and contingent earn-out shares
4.32a
0.12a
0a
Total other income, net
88.68a
47.29a
9.15a
Loss before income taxes
-600.85a
-439.89a
-249.13a
Benefit from income taxes
0.75a
3.52a
0.42a
Net loss
-600.09a
-436.37a
-248.71a
Limited Data Preview
You are viewing a limited preview of Revolution Medicines’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Revolution Medicines’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Revolution Medicines’s data sources below and access millions more through our Disclosure Search.

a. Revolution Medicines's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?